A mock FDA inspection is a realistic, simulated FDA audit conducted by experienced compliance professionals to evaluate your facility’s readiness for an actual FDA inspection.
US manufacturers of pharmaceuticals, biologics, medical products, and GMP-regulated operations preparing for routine, for-cause, or pre-approval FDA inspections.
It identifies compliance gaps, documentation issues, and staff readiness concerns before the FDA arrives, allowing corrective actions to be implemented proactively.
Our mock inspections follow FDA inspection protocols, investigator behavior, documentation requests, and interview techniques to closely replicate real inspection conditions.
A deviation or nonconformance occurs when a process, system, or product does not meet approved procedures, specifications, or regulatory requirements.
Poorly conducted investigations are a common FDA citation. FDA-aligned investigations ensure root causes are correctly identified and corrective actions are effective.
Yes. We provide hands-on coaching and training to strengthen internal investigation skills and documentation quality.
GMP quality systems are the policies, procedures, and controls that ensure products are consistently manufactured and controlled according to quality standards.
Yes. We support companies in designing, implementing, and maintaining GMP-compliant quality systems aligned with FDA regulations.
Absolutely. We provide continuous GMP support, internal audits, system maintenance, and regulatory guidance.
Pharmaceutical, biologics, API manufacturers, CDMOs, and other FDA-regulated companies operating in the United States or supplying the US market.
Yes. We support startups establishing FDA-compliant quality systems and established organizations seeking remediation, inspection readiness, or system optimization.
Yes. We provide support for FDA Form 483 responses, warning letter remediation, and long-term compliance improvements.
A Corrective and Preventive Action (CAPA) system is a structured process used to identify, correct, and prevent quality issues within a GMP environment.
CAPA systems should be assessed when there are recurring issues, FDA observations, internal audit findings, or concerns about effectiveness.
We evaluate CAPA processes, metrics, root cause analysis, and effectiveness checks, then implement FDA-compliant improvements tailored to your operations.
Data integrity ensures that data is accurate, complete, consistent, and reliable throughout its lifecycle, in compliance with FDA expectations.
Data integrity failures can compromise product quality and patient safety, making it a frequent focus during FDA inspections.
We evaluate systems, processes, access controls, audit trails, documentation practices, and data governance to identify and remediate risks.
Yes. We improve SOPs, batch records, logs, and documentation practices to align with FDA guidance and inspection expectations.
A mock FDA inspection is a realistic, simulated FDA audit conducted by experienced compliance professionals to evaluate your facility’s readiness for an actual FDA inspection.
US manufacturers of pharmaceuticals, biologics, medical products, and GMP-regulated operations preparing for routine, for-cause, or pre-approval FDA inspections.
It identifies compliance gaps, documentation issues, and staff readiness concerns before the FDA arrives, allowing corrective actions to be implemented proactively.
Our mock inspections follow FDA inspection protocols, investigator behavior, documentation requests, and interview techniques to closely replicate real inspection conditions.
Pharmaceutical, biologics, API manufacturers, CDMOs, and other FDA-regulated companies operating in the United States or supplying the US market.
Yes. We support startups establishing FDA-compliant quality systems and established organizations seeking remediation, inspection readiness, or system optimization.
Yes. We provide support for FDA Form 483 responses, warning letter remediation, and long-term compliance improvements.
A deviation or nonconformance occurs when a process, system, or product does not meet approved procedures, specifications, or regulatory requirements.
Poorly conducted investigations are a common FDA citation. FDA-aligned investigations ensure root causes are correctly identified and corrective actions are effective.
Yes. We provide hands-on coaching and training to strengthen internal investigation skills and documentation quality.
A Corrective and Preventive Action (CAPA) system is a structured process used to identify, correct, and prevent quality issues within a GMP environment.
CAPA systems should be assessed when there are recurring issues, FDA observations, internal audit findings, or concerns about effectiveness.
We evaluate CAPA processes, metrics, root cause analysis, and effectiveness checks, then implement FDA-compliant improvements tailored to your operations.
GMP quality systems are the policies, procedures, and controls that ensure products are consistently manufactured and controlled according to quality standards.
Yes. We support companies in designing, implementing, and maintaining GMP-compliant quality systems aligned with FDA regulations.
Absolutely. We provide continuous GMP support, internal audits, system maintenance, and regulatory guidance.
Data integrity ensures that data is accurate, complete, consistent, and reliable throughout its lifecycle, in compliance with FDA expectations.
Data integrity failures can compromise product quality and patient safety, making it a frequent focus during FDA inspections.
We evaluate systems, processes, access controls, audit trails, documentation practices, and data governance to identify and remediate risks.
Yes. We improve SOPs, batch records, logs, and documentation practices to align with FDA guidance and inspection expectations.
Don’t wait for an FDA inspection to expose compliance gaps. Our experts help US manufacturers identify risks, strengthen quality systems, and confidently face regulatory scrutiny.
